However, guidelines for interpreting vitamin D levels must consider non-bone-related outcomes like hypertension, BMI, cardiovascular diseases (CVDs), and glucose and insulin metabolism measurements [15,16]. This evidence concerns the gene INS and cardiovascular disorder.